Literature DB >> 34040295

Fever of Unknown Origin: 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Showing Renal Cyst Infection in Autosomal Dominant Polycystic Kidney Disease.

Punit Sharma1.   

Abstract

Fever of unknown origin (FUO) is a convoluted clinical dilemma. It can be caused by infective, inflammatory, malignant, and other pathologies. The identification of etiopathogenesis is essential for instituting definitive management. 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography-computed tomography (PET-CT) is now an integral part of FUO management. We present the case of a 60-year-old female with autosomal dominant polycystic kidney disease (ADPKD), where the infected renal cyst was detected as the cause of FUO on18F-FDG PET-CT. Copyright:
© 2021 Indian Journal of Nuclear Medicine.

Entities:  

Keywords:  18F-fluorodeoxyglucose; autosomal dominant polycystic kidney disease; fever of unknown origin; positron emission tomography-computed tomography

Year:  2021        PMID: 34040295      PMCID: PMC8130681          DOI: 10.4103/ijnm.IJNM_139_20

Source DB:  PubMed          Journal:  Indian J Nucl Med        ISSN: 0974-0244


Introduction

18F-fluorodeoxyglucose (18F-FDG) positron emission tomography-computed tomography (PET-CT) is now an integral part of fever of unknown origin (FUO) management because of its ability to demonstrate the etiology in a large proportion of cases.[1] In a patient without potential diagnostic clues, 18F-FDG PET-CT is recommended as first-line imaging.[2] Patients with autosomal dominant polycystic kidney disease (ADPKD) are at increased risk of infection because of the presence of multiple renal cysts as well as often accompanying renal dysfunction.[3] The detection of cyst infection with conventional anatomical imaging such as ultrasonography (USG), CT, and magnetic resonance imaging (MRI) is challenging.[4] 18F-FDG PET-CT has been shown to be a promising technique for the detection of cyst infection in ADPKD.[5]

Case Report

A 60-year-old female presented to the hospital with a history of fever of 2 weeks duration, which was evaluated on an outpatient basis for one more week, with three outpatient visits. It was moderate-to-high grade and associated with no localizing symptoms. There was some abdominal fullness. She was a known case of ADPKD, resulting in end-stage renal disease (ESRD) and was on maintenance hemodialysis (MHD). She also had hypertension and diabetes mellitus. On clinical examination apart from bilateral renal masses, there was no other major finding. There was no flank tenderness. Blood picture showed anemia (hemoglobin: 8.1 g/dL), neutrophilic leukocytosis (total count: 18,900/mL, 93% neutrophils) and raised C-reactive protein (32 mg/L) suggesting infection. Suspecting renal cyst infection, USG of the abdomen was done, which was noncontributory and showed enlarged bilateral kidney with extensive cysts, some of which showed internal debris. Whole-body contrast-enhanced (patient was on MHD) 18F-FDG PET-CT [Figure 1] was made to localize the cause of fever. Maximum intensity projection PET images (A) showed focal areas of increased18F-FDG uptake in bilateral lumbar regions in the abdomen (arrows). Transaxial (B) and coronal (C) contrast-enhanced CT images showed bilateral grossly enlarged kidneys with the renal parenchyma replaced completely with cysts of variable sizes. Fused transaxial (D) and coronal (E) PET-CT images revealed increased peripheral18F-FDG uptake in two cysts (arrows), one in the right kidney mid polar region (maximum standardized uptake value [SUV max] 8.5) and another in the left kidney lower pole region (SUV max 5.1). Findings were suggestive of cyst infection. No other significant abnormality was seen in the rest of the body. The patient was treated with intravenous broad-spectrum antibiotics but failed to respond. Aspiration of the right renal mid-pole cyst under guidance showed turbid fluid, which grew Klebsiella pneumoniae on culture, resistant to many antibiotics. She was started on sensitive antibiotics but achieved no response. Considering the risk of septicemia and the inability of systemically administered antibiotics to reach the cysts, the patient underwent bilateral nephrectomy. Postnephrectomy gross examination showed bilateral multiple subcapsular cysts with purulent collection in three cysts and clear to brown fluid in others. Microscopic examination showed cysts (dilated tubules and collector ducts) lined by cuboidal or flattened epithelium containing an eosinophilic fluid. The parenchyma between cysts was represented by very few atrophic/compressed but still functional nephrons, along with interstitial fibrosis and chronic inflammation. There was no evidence of renal cell carcinoma in either kidney. The fever subsided a few days after surgery. She is awaiting transplantation.
Figure 1

Maximum intensity projection positron emission tomography images (a) showed focal areas of increased 8F-fluorodeoxyglucose uptake in bilateral lumbar regions in abdomen (arrows). Transaxial (b) and coronal (c) contrast-enhanced computed tomography images showed bilateral enlarged kidneys with the renal parenchyma replaced completely with cysts of variable sizes. Fused transaxial (d) and coronal (e) positron emission tomography-computed tomography images revealed increased peripheral fluorodeoxyglucose uptake in two cysts (arrows), one in the right kidney mid polar region (maximum standardized uptake value 8.5) and another in the left kidney lower pole region (maximum standardized uptake value 5.1)

Maximum intensity projection positron emission tomography images (a) showed focal areas of increased 8F-fluorodeoxyglucose uptake in bilateral lumbar regions in abdomen (arrows). Transaxial (b) and coronal (c) contrast-enhanced computed tomography images showed bilateral enlarged kidneys with the renal parenchyma replaced completely with cysts of variable sizes. Fused transaxial (d) and coronal (e) positron emission tomography-computed tomography images revealed increased peripheral fluorodeoxyglucose uptake in two cysts (arrows), one in the right kidney mid polar region (maximum standardized uptake value 8.5) and another in the left kidney lower pole region (maximum standardized uptake value 5.1)

Discussion

ADPKD is a hereditary condition caused due to mutation in PKD-1 or PKD-2 gene, which leads to the development of multiple renal cysts.[3] While it is usually asymptomatic in childhood, symptoms begin to appear with increasing age. Patients can present with flank pain and hematuria, or nonspecific gastrointestinal symptoms. Hypertension due to activation of the renin-angiotensin system is common. ESRD develops over the course of time. Cyst infection is a common but sinister complication and can present with fever and flank pain. However, these symptoms can also be seen in cyst hemorrhage, pyelonephritis, and nephrolithiasis; hence, further evaluation is needed to reach the correct diagnosis.[6] The reference standard is the analysis of the cyst fluid, but aspiration is fraught with the risk of complications such as bleeding, rupture, and contamination of adjacent cysts, and is therefore rarely performed. It was performed in this case to check the antibiotic sensitivity as the patient was not responding even to high-end antibiotics. On conventional anatomical imaging with USG, CT, or MRI, it is difficult to differentiate infected and noninfected renal cysts.[4] Diffusion-weighted MRI has shown some promise, but results are still mixed.[7] 18F-FDG PET-CT is now an integral part of FUO management. Because of the nonspecific nature of18F-FDG, it is taken up by leukocytes as well as malignant cells, thereby allowing detection of a wide range of malignant, infective and inflammatory diseases which could present with FUO.[12] It has shown promising results for the detection of infection in renal cysts associated with ADPKD. Pijl et al. showed a sensitivity of 88.9%, a specificity of 75.0%, a positive predictive value (PPV) of 84.2%, and a negative predictive value (NPV) of 81.8% for the diagnosis of cyst infection in ADPKD.[8] In another study, Kwon et al. showed a sensitivity of 85.7%, specificity of 87.5%, PPV of 85.7%, and NPV of 87.5% for the same purpose.[9] More recently, Neuville et al. suggested a 4-point visual scoring system (with respect to blood pool and liver) for the diagnosis of cyst infection in ADPKD.[10] The visual assessment of PET-CT images reached a sensitivity of 73.1% and a specificity of 70.6%. Using the 4-point scale, an18F-FDG score ≥3 (i.e., cyst uptake >liver) improved the specificity to 85.3%.

Conclusion

18F-FDG PET-CT is an important imaging modality in the management of patients with FUO. In patients with ADPKD, it can demonstrate cyst infection with higher sensitivity and specificity than conventional anatomical imaging, thereby providing a reliable noninvasive tool in this setting, as demonstrated in the case presented above.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  10 in total

1.  Spectrum of 18F-FDG PET/CT findings in patients presenting with fever of unknown origin.

Authors:  Aftab Hasan Nazar; Niraj Naswa; Punit Sharma; Ramya Soundararajan; Chandrasekhar Bal; Arun Malhotra; Rakesh Kumar
Journal:  AJR Am J Roentgenol       Date:  2012-07       Impact factor: 3.959

2.  The use of a visual 4-point scoring scale improves the yield of 18F-FDG PET-CT imaging in the diagnosis of renal and hepatic cyst infection in patients with autosomal dominant polycystic kidney disease.

Authors:  Marie F Neuville; Pierre Lovinfosse; Alexandre Jadoul; Marie Thys; Laurence Seidel; Roland Hustinx; François Jouret
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-06-15       Impact factor: 9.236

3.  18F-FDG PET/CT in Autosomal Dominant Polycystic Kidney Disease Patients with Suspected Cyst Infection.

Authors:  Jordy P Pijl; Andor W J M Glaudemans; Riemer H J A Slart; Thomas C Kwee
Journal:  J Nucl Med       Date:  2018-04-13       Impact factor: 10.057

Review 4.  Evaluation and management of pain in autosomal dominant polycystic kidney disease.

Authors:  Marie C Hogan; Suzanne M Norby
Journal:  Adv Chronic Kidney Dis       Date:  2010-05       Impact factor: 3.620

Review 5.  Fever of Unknown Origin: the Value of FDG-PET/CT.

Authors:  Ilse J E Kouijzer; Catharina M Mulders-Manders; Chantal P Bleeker-Rovers; Wim J G Oyen
Journal:  Semin Nucl Med       Date:  2017-12-08       Impact factor: 4.446

6.  Diagnostic performance of 18F-FDG-labeled white blood cell PET/CT for cyst infection in patients with autosomal dominant polycystic kidney disease: a prospective study.

Authors:  Hyun Woo Kwon; Ho-Young Lee; Young-Hwan Hwang; Hayne Cho Park; Curie Ahn; Keon Wook Kang
Journal:  Nucl Med Commun       Date:  2016-05       Impact factor: 1.690

Review 7.  Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities.

Authors:  François Jouret; Renaud Lhommel; Olivier Devuyst; Laurence Annet; Yves Pirson; Ziad Hassoun; Nada Kanaan
Journal:  Nephrol Dial Transplant       Date:  2012-10       Impact factor: 5.992

Review 8.  Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2016.

Authors:  Fouad T Chebib; Vicente E Torres
Journal:  Am J Kidney Dis       Date:  2015-10-31       Impact factor: 8.860

9.  FDG-PET/CT for diagnosis of cyst infection in autosomal dominant polycystic kidney disease.

Authors:  J P Pijl; T C Kwee; R H J A Slart; A W J M Glaudemans
Journal:  Clin Transl Imaging       Date:  2018-02-12

10.  Intracystic magnetic resonance imaging in patients with autosomal dominant polycystic kidney disease: features of severe cyst infection in a case-control study.

Authors:  Tatsuya Suwabe; Yoshifumi Ubara; Toshiharu Ueno; Noriko Hayami; Junichi Hoshino; Aya Imafuku; Masahiro Kawada; Rikako Hiramatsu; Eiko Hasegawa; Naoki Sawa; Satoshi Saitoh; Itsuko Okuda; Kenmei Takaichi
Journal:  BMC Nephrol       Date:  2016-11-09       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.